203 related articles for article (PubMed ID: 9033160)
1. Sedative-hypnotic use by the elderly: effects on hospital length of stay and costs.
Yuen EJ; Zisselman MH; Louis DZ; Rovner BW
J Ment Health Adm; 1997; 24(1):90-7. PubMed ID: 9033160
[TBL] [Abstract][Full Text] [Related]
2. Sedative-hypnotic use and increased hospital stay and costs in older people.
Zisselman MH; Rovner BW; Yuen EJ; Louis DZ
J Am Geriatr Soc; 1996 Nov; 44(11):1371-4. PubMed ID: 8909355
[TBL] [Abstract][Full Text] [Related]
3. Drug utilization review of sedative/hypnotic agents in Texas Medicaid patients. Texas Medicaid Vendor Drug Program Drug Utilization Review Board.
Seltzer JK; Kurt TL; Knodel LC; Dean B; Burch C
J Am Pharm Assoc (Wash); 2000; 40(4):495-9. PubMed ID: 10932458
[TBL] [Abstract][Full Text] [Related]
4. Reducing Sedative-Hypnotics Among Hospitalized Patients: a Multi-centered Study.
Soong C; Ethier C; Lee Y; Othman D; Burry L; Wu PE; Ng KA; Matelski J; Liu B
J Gen Intern Med; 2022 Aug; 37(10):2345-2350. PubMed ID: 34981347
[TBL] [Abstract][Full Text] [Related]
5. Sedative-hypnotic treatment in an acute psychiatric setting: comparison with best practice guidance.
Wheeler A; Kairuz T; Sheridan J; McPhee E
Pharm World Sci; 2007 Dec; 29(6):603-10. PubMed ID: 17333495
[TBL] [Abstract][Full Text] [Related]
6. New and Persistent Sedative-Hypnotic Use After Adjuvant Chemotherapy for Breast Cancer.
Cogan JC; Raghunathan RR; Beauchemin MP; Accordino MK; Huang Y; Elkin EB; Melamed A; Wright JD; Hershman DL
J Natl Cancer Inst; 2022 Dec; 114(12):1698-1705. PubMed ID: 36130058
[TBL] [Abstract][Full Text] [Related]
7. Sedative-hypnotic drug use among community-dwelling elderly in Taiwan.
Tseng HY; Yu SH; Lee CY; Huang WH; Huang SL; Wu CS; Chiu YF; Hsiung CA
Int Psychogeriatr; 2018 Jul; 30(7):957-965. PubMed ID: 29559028
[TBL] [Abstract][Full Text] [Related]
8. The use of sedative-hypnotic drugs in a university teaching hospital.
O'Reilly R; Rusnak C
CMAJ; 1990 Mar; 142(6):585-9. PubMed ID: 2369436
[TBL] [Abstract][Full Text] [Related]
9. A randomized controlled trial of a drug use review intervention for sedative hypnotic medications.
Smith DH; Christensen DB; Stergachis A; Holmes G
Med Care; 1998 Jul; 36(7):1013-21. PubMed ID: 9674619
[TBL] [Abstract][Full Text] [Related]
10. Sedative-hypnotic medicines and falls in community-dwelling older adults: a cost-effectiveness (decision-tree) analysis from a US Medicare perspective.
Tannenbaum C; Diaby V; Singh D; Perreault S; Luc M; Vasiliadis HM
Drugs Aging; 2015 Apr; 32(4):305-14. PubMed ID: 25825121
[TBL] [Abstract][Full Text] [Related]
11. Sedative-Hypnotic Use Among Older Adults Participating in Anxiety Research.
Conti EC; Stanley MA; Amspoker AB; Kunik ME
Int J Aging Hum Dev; 2017 Jun; 85(1):3-17. PubMed ID: 28019122
[TBL] [Abstract][Full Text] [Related]
12. Risk of psychiatric disorders in patients with chronic insomnia and sedative-hypnotic prescription: a nationwide population-based follow-up study.
Chung KH; Li CY; Kuo SY; Sithole T; Liu WW; Chung MH
J Clin Sleep Med; 2015 Apr; 11(5):543-51. PubMed ID: 25766696
[TBL] [Abstract][Full Text] [Related]
13. The impact of sedative-hypnotic use on sleep symptoms in elderly nursing home residents.
Monane M; Glynn RJ; Avorn J
Clin Pharmacol Ther; 1996 Jan; 59(1):83-92. PubMed ID: 8549038
[TBL] [Abstract][Full Text] [Related]
14. Effect of Sedative-Hypnotic Medicines on Mortality in Peritoneal Dialysis Patients with Sleep Disorders: A Retrospective Cohort Study.
Zhou Y; Yin P; Li B; Li J; Huang N; Wu H; Ullah H; Yang X; Yu X
Blood Purif; 2018; 45(1-3):95-101. PubMed ID: 29402860
[TBL] [Abstract][Full Text] [Related]
15. An Implementation Guide to Promote Sleep and Reduce Sedative-Hypnotic Initiation for Noncritically Ill Inpatients.
Soong C; Burry L; Cho HJ; Gathecha E; Kisuule F; Tannenbaum C; Vijenthira A; Morgenthaler T
JAMA Intern Med; 2019 Jul; 179(7):965-972. PubMed ID: 31157831
[TBL] [Abstract][Full Text] [Related]
16. Environmental scan of current strategies to decrease sedative-hypnotic drug use and promote sleep in hospital patients.
Neville HL; Shaw J; VanIderstine C; Burgess S; Dearing M; Isenor JE; Toombs K; Bowles SK
Int J Clin Pharm; 2023 Oct; 45(5):1062-1073. PubMed ID: 37773305
[TBL] [Abstract][Full Text] [Related]
17. New sedative/hypnotic dosing guidelines.
Simonson W
Geriatr Nurs; 2014; 35(4):306-7. PubMed ID: 25012987
[No Abstract] [Full Text] [Related]
18. Effects of sleep disorders and sedative-hypnotic medications on health-related quality of life in dialysis patients.
Zheng C; Xu J; Chen C; Lin F; Shao R; Lin Z; Liu Y; Zhou Y
Int Urol Nephrol; 2019 Jan; 51(1):163-174. PubMed ID: 30467784
[TBL] [Abstract][Full Text] [Related]
19. Sedative-hypnotic drug use and ageing.
Morgan K
Arch Gerontol Geriatr; 1983 Nov; 2(3):181-99. PubMed ID: 6360058
[TBL] [Abstract][Full Text] [Related]
20. Clinical sedation scores as indicators of sedative and analgesic drug exposure in intensive care unit patients.
Masica AL; Girard TD; Wilkinson GR; Thomason JW; Truman Pun B; Nair UB; Light RW; Canonico AE; Dunn J; Pandharipande P; Shintani AK; Ely EW
Am J Geriatr Pharmacother; 2007 Sep; 5(3):218-31. PubMed ID: 17996661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
